CoChat

Naloxone in the Treatment of Acute Dissociative States in Female Patients with Borderline Personality Disorder

Philipsen, A., Schmahl, C., Lieb, K. · 2004 · Pharmacopsychiatry

The DOI matches its Crossref record.

Abstract

BACKGROUND: Acute dissociative states are common in patients with borderline personality disorder (BPD). However, there are no established pharmacotherapeutic treatment options for this severe clinical condition. METHODS: The effect of 0.4 mg naloxone administered intravenously in acute dissociative states was examined as compared to placebo in a double-blind crossover study in nine patients who met DSM-IV-criteria for BPD. Dissociative symptoms before and 15 min after a single dose of naloxone or saline placebo were assessed using a self-rating instrument for dissociation and aversive inner tension (DSS) and the observer-based items of the Clinician Administered Dissociative States Scale (CADSS). RESULTS: Dissociative symptoms before treatment with naloxone or saline placebo were moderate to severe. After injection of either naloxone or placebo, dissociative symptoms significantly decreased on the DSS (p < 0.01) and the CADSS (p < 0.05). However, there were no significant differences between naloxone and placebo in the reduction of symptoms. Patients who showed the most prominent response to naloxone fulfilled the highest number of DSM-IV-criteria for BPD. CONCLUSIONS: Although it is difficult to draw definite conclusions from this small sample of patients, this study does not support the assumption that naloxone in a single dose of 0.4 mg is superior to placebo in acute dissociative states in patients with BPD. Further studies will investigate whether patients benefit from naloxone in a higher dose or whether subgroups of patients with BPD profit from naloxone in acute dissociative states.

Overview

Integrity signals

Registry

Crossref · 10.1055/s-2004-827243

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cited by

See all 80

Metadata

Authors
Philipsen, A., Schmahl, C., & Lieb, K.
Affiliations
University of Freiburg (DE)
Venue
Pharmacopsychiatry
Published
2004-09
Volume
37
Issue
5
Pages
196-199
ISSN
  • 0176-3679 (ISSN-L)
  • 1439-0795
OpenAlex
W2009952140
Cited by
80
References
0
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 6 · 2018: 2 · 2017: 5 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 7 · 2012: 4
FWCI
5.20
Type
journal article
Language
de
Open access
closed
Locations
  • Pharmacopsychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
  • Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
Keywords
naloxone, borderline personality disorder, dissociative states, female patients, intravenous administration, dissociation, placebo comparison, pharmacotherapy
MeSH terms
Acute Disease, Adult, Borderline Personality Disorder, Dissociative Disorders, Double-Blind Method, Female, Humans, Injections, Intravenous, Naloxone, Narcotic Antagonists, Severity of Illness Index, Cross-Over Studies, Diagnostic and Statistical Manual of Mental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Naloxone in the Treatment of Acute Dissociative States in Female Patients with Borderline Personality Disorder. https://app.cochat.ai/papers/10.1055/s-2004-827243
The paper
Philipsen, A., Schmahl, C., & Lieb, K. (2004). Naloxone in the Treatment of Acute Dissociative States in Female Patients with Borderline Personality Disorder. Pharmacopsychiatry. https://doi.org/10.1055/s-2004-827243

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.